Europe's best young group leaders win EMBO support

EMBO Young Investigators carry an influential recommendation. Selected by EMBO Members for the high standard of their research, they join a network of some of Europe's best young life scientists. The three-year programme offers a range of benefits designed to smooth the transition between setting up independently and establishing a reputation in the scientific community.

The aim is to raise the profile of the young investigators and help them to attract new collaborations and funding. Gerlind Wallon, manager of the programme, explains: "The EMBO Young Investigator Programme offers a level of support and distinction that is hard to find at this stage in a scientist's career. It tells the scientific community and funding bodies that EMBO is convinced of the quality of your research and that's an impressive credential."

The EMBO Young Investigator Programme supports researchers who are within four years of establishing their first independent laboratories. Benefits include networking support through a mentorship programme, annual meeting and lab exchanges, as well as professional training and an annual award of 15,000 euro. The programme has been promoting outstanding young group leaders in Europe since 2000. Currently it supports a network of 70 life scientists.

2006 EMBO Young Investigators

François-Xavier Barre (FR) Cell division in bacteria CNRS Centre for Molecular Genetics, Gif-sur-Yvette

Sigal Ben-Yehuda (IL) DNA damage depair in sporulation Hebrew University, Jerusalem

Simon Boulton (UK) DNA damage response in C. elegans Cancer Research UK London Research Institute, South Mimms

Dirk Bumann (DE) Salmonella–host interactions Hannover Medical School

Jérôme Cavaille (FR) Function of non-coding RNA University of Toulouse

Vincenzo Costanzo (UK) DNA damage response in Xenopus laevis Cancer Research UK London Research Institute, South Mimms

François Fuks (BE) DNA methylation in mammals Free University of Brussels

Johanna Ivaska (FI) Integrin traffic and signalling in cancer Turku Centre for Biotechnology

Bruno Klaholz (FR) Complexes in gene expression Institute of Genetics and Molecular and Cellular Biology (IGBMC), Strasbourg

Jean-Christophe Marine (BE) Key modifiers of p53 Flanders Interuniversity Institute for Biotechnology (VIB), Ghent

Annette Oxenius (CH) Host–pathogen interactions Institute of Microbiology, ETH Zürich

Philippe Pasero (FR) Maintenance of genome integrity CNRS Institute of Human Genetics, Montpellier

Maria Rescigno (IT) Dendritic cells in infection and cancer European Institute of Oncology (IEO), Milan

John Rouse (UK) Regulators of genome stability MRC Protein Phosphorylation Unit, University of Dundee

Dirk Schübeler (CH) Dynamics and propagation of epigenetic states Friedrich Miescher Institute, Basel

Luca Scorrano (IT) Mitochondria-shaping proteins Venetian Institute of Molecular Medicine, Padova

Victor Sourjik (DE) Bacterial chemotaxis ZMBH, University of Heidelberg

Irina Stancheva (UK) Epigenetic silencing Wellcome Trust Centre for Cell Biology, University of Edinburgh

Jussi Taipale (FI) Growth control and cancer Biocentrum, University of Helsinki

Miltos Tsiantis (UK) Comparative leaf development University of Oxford

Antonella Viola (IT) T-cell activation Venetian Institute of Molecular Medicine, Padova

###

Related links

About EMBO
http://www.embo.org/about_embo/index.html

EMBO Young Investigator Programme
http://www.embo.org/yip/index.html

EMBO Installation Grants
http://www.embo.org/sdig/index.html


Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on PsychCentral.com. All rights reserved.

 

 

Ordinary riches can be stolen; real riches cannot. In your soul are infinitely precious things that cannot be taken from you.
-- Oscar Wilde